Phase 2 Stomach Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who have been diagnosed with a locally advanced, inoperable, or metastatic solid tumour cancer confirmed by a tissue or cell sample — specifically colorectal, biliary tract, bladder or urothelial tract, cervical, endometrial, breast, or other solid tumour cancers (not including non-small cell lung cancer)
- People who are 18 years of age or older, or who are at or above the legal age of consent in their country
- People who have already received standard treatments appropriate for their cancer type and stage, or for whom no satisfactory alternative treatments exist
- People whose cancer has a specific genetic change called an "activating HER2 mutation," as confirmed by testing
- People who have at least one area of cancer in the body that can be measured using standard imaging criteria (known as RECIST 1.1 guidelines)
Who may not be able to join:
- People whose primary cancer diagnosis is non-small cell lung cancer (NSCLC)
- People who have previously been treated with a type of drug called a HER2 tyrosine kinase inhibitor (TKI) (confirm with trial site if unsure whether a past treatment falls into this category)
- People who currently have active cancer spread to the brain
- People who have a serious illness that is not currently under control
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Phone: (+)1-888-84 22937
Australian sites
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
3 site(s) in Australia. Confirm current status and contact details directly with the trial site.
Primary endpoints
Objective Response Rate (ORR) per RECIST 1.1 as assessed by BICR
Can't join this trial?
Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.